Prognostic value of plasma circulating tumor DNA fraction across ...

Background. Genomic analysis of circulating tumor DNA (ctDNA) is increasingly incorporated into the clinical management of patients with ...

Prognostic value of plasma circulating tumor DNA fraction ... - PubMed

Plasma ctDNA TF is a pragmatic, independent prognostic biomarker across four advanced cancers with potential to guide clinical conversations ...

Genomic analysis of circulating tumor DNA (ctDNA) is increasingly incorporated into the clinical management of patients with advanced cancer ...

Prognostic value of plasma circulating tumor DNA fraction across ...

The study found plasma ctDNA TF is a pragmatic, independent prognostic biomarker across four advanced cancers with potential to guide clinical discussions ...

Prediction of plasma ctDNA fraction and prognostic implications of ...

ctDNA fraction (ctDNA%) is the proportion of tumor-derived cfDNA and is an emerging prognostic factor across cancers and clinical scenarios.

Prognostic significance of plasma circulating tumor DNA fraction in ...

Among the 189 patients who underwent systemic treatment post-ctDNA profiling, elevated TF correlated with significantly poorer PFS (2.6 vs 4.3 ...

Prognostic value of plasma circulating DNA fraction in real-world ...

Tumor fraction (TF), a measure of the relative quantity of circulating tumor DNA (ctDNA) derived from peripheral blood liquid biopsies (LBx), is an emerging ...

Prognostic value of plasma circulating tumor DNA fraction across ...

Exploratory analysis showed that TF remained consistently prognostic across a wide range of cutpoints. Conclusions: Plasma ctDNA TF is a pragmatic, independent ...

Prognostic value of circulating tumor DNA in different cancer types ...

All patients underwent baseline ULP-WGS of plasma cfDNA and were categorized as ctDNA positive (tumor fraction ≥10%) or negative (tumor fraction ...

(PDF) Prognostic value of plasma circulating tumor DNA fraction ...

Exploratory analysis showed TF remained consistently prognostic across a wide range of cutpoints. Conclusions Plasma ctDNA TF is a pragmatic, independent ...

Prognostic value of plasma circulating tumor DNA fraction across ...

Learn more about Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study. 10/05/2022.

1623P Prognostic value of circulating tumour DNA fraction in ...

After adjusting for known prognostic factors, patients with undetectable ctDNA levels demonstrated an 89% (90% Credible Intervals (CrI) 1.44, 2.52) longer PFS ...

Ryon Graf, PhD on LinkedIn: Prognostic value of plasma circulating ...

I am pleased to share the news that our team's manuscript "Prognostic value of plasma circulating tumor DNA fraction across four common ...

Relationship of tumor fraction in circulating tumor DNA with ...

ctDNA TF is a prognostic biomarker in aUC with potential to inform expected longevity of patients.

Plasma ctDNA as a Treatment Response Biomarker in Metastatic ...

Recent data suggest that measuring on-treatment changes in the amount or proportion of ctDNA in peripheral blood plasma may accurately identify ...

Circulating tumor DNA clearance predicts prognosis across ...

Results: The results of this study revealed that higher ctDNA abundance (P=0.012) and mutation count (P=8.5×10−4) at baseline are associated with shorter OS. We ...

Analysis of the Prognostic Significance of Circulating Tumor DNA in ...

The presence of ≤ 1 versus > 1 alteration on ctDNA analysis was strongly associated with inferior OS with a median OS of 26.1 versus 8.8 months, respectively ( ...

Prognostic Value of Low-Pass Whole Genome Sequencing of ...

Recent studies have shown that analysis of ctDNA can identify genomic driver alterations present in matched metastatic prostate cancer (mPC) ...

Prognostic value of plasma circulating tumor DNA fraction across ...

Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study ... Authors: Z.R. Reichert; T.M. Morgan; G.

Brian Alexander on LinkedIn: Prognostic value of plasma circulating ...

I am pleased to share the news that our team's manuscript "Prognostic value of plasma circulating tumor DNA fraction across four common cancer ...